Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2/3 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia 6Lymphoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Osteosarcoma 2Leukemia, T-Cell 2Leukemia, Myeloid, Acute 2Gestational Trophoblastic Disease 2Burkitt Lymphoma 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Sarcoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Neoplasms, Connective and Soft Tissue 1Neoplasms, Connective Tissue 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Large Granular Lymphocytic 1Leukemia, Biphenotypic, Acute 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms 1Bone Neoplasms 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Methotrexate 2Vacuum Curettage 1Surgical Procedures, Operative 1Leucovorin 1Letrozole 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Gestational Trophoblastic Disease × Methotrexate × Clear all
NCT03885388 2019-03-21

Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6

Women's Hospital School Of Medicine Zhejiang University

Phase 2/3 Unknown
300 enrolled
Gynecologic

Gestational Trophoblastic Disease, Drug-Related Side Effects and Adverse Reactions

NCT02606539 2017-03-22

SVCGTN

Mansoura University

Phase 2/3 Unknown
20 enrolled
Gynecologic

Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡